Company intelligence / Profile preview

numares

Regensburg, Bavaria, Germanynumares.com ↗
Ownership
Private
Employees
~60
Development stage
Commercial
01

Overview

Numares has commercialized several CE-marked IVD tests on its AXINON platform in Europe and received FDA clearance for its LDL-p Test System. The company’s pipeline includes advanced diagnostic assays targeting cardiovascular risk, kidney function/transplantation outcomes, liver cancer detection, and multiple sclerosis. Clinical studies are ongoing to expand regulatory approvals and validate new indications. Strategic collaborations with Mayo Clinic Laboratories and Oxford University support further clinical validation.

Therapeutic areas
NephrologyOncologyMetabolic DisordersGastroenterologyCardiovascularNeurology
Modalities
Diagnostic test (in vitro diagnostic)Device (NMR-based platform)Software/AI-enabled diagnostics
Industry
Metabolite Diagnostics
02

Partnerships

Mayo Clinic LaboratoriesBruker CorporationOxford Universitymajor U.S. laboratory chains/laboratory networks.

Beyond the preview

Go deeper on numares.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on numares.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call